1 result(s) for MLN8237
| PI Name | Protocol # | Title |
|---|---|---|
| Tomasz Beer | IRB00007590 | A Phase 1 Study of MLN8237, an Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen |
You may qualify for additional trials within our Phase 1 Program

